Fuse Biotherapeutics

Fuse Biotherapeutics, led by co-founder and CEO Paul Y. Song, M.D., is a biotechnology company dedicated to developing immunomodulatory therapies for cancer patients. Its treatments integrate multiple steps of the immune response in a rational manner to effectively target threats without naturally disrupting the system, thereby protecting healthy tissue.